Can MMR and Monkeypox Vaccines Be Given Together?
Yes, MMR and monkeypox (JYNNEOS) vaccines can be administered simultaneously at different anatomic sites, based on established principles for co-administering live vaccines and the absence of any contraindications. 1
Evidence-Based Rationale
FDA-Approved Guidance for MMR Co-Administration with Live Vaccines
The M-M-R II package insert explicitly states that MMR vaccine can be administered concurrently with other live viral vaccines at separate sites. If not given on the same day, live vaccines must be separated by at least one month (28 days) to avoid potential immune interference. 1
This guidance applies to all live viral vaccines, which includes JYNNEOS (a live, nonreplicating vaccinia virus vaccine). 2
ACIP Principles Supporting Simultaneous Administration
ACIP has consistently recommended that live and inactivated vaccines can be administered simultaneously without impairing antibody responses or increasing adverse reaction rates. This principle has been validated across multiple vaccine combinations including MMR with varicella, yellow fever, and other live vaccines. 3
When vaccines are not given on the same day, ACIP requires a minimum 4-week interval between live virus vaccines to maintain optimal immunogenicity. 4
Simultaneous administration is particularly important when there is uncertainty about patient follow-up or when immediate protection against multiple diseases is needed. 5, 3
Practical Implementation
Injection Technique Requirements
Each vaccine must be administered at a separate anatomic site using separate syringes. Never mix vaccines in the same syringe. 3, 6
MMR is given subcutaneously (0.5 mL), while JYNNEOS can be administered either subcutaneously (0.5 mL) or intradermally (0.1 mL) depending on the indication and patient age. 7, 2
Timing Considerations
If you choose to administer both vaccines on the same day, proceed without delay—the evidence supports immediate co-administration. 5, 6
If you cannot give them simultaneously, you must wait at least 28 days between doses to avoid immune interference. 1, 4
Do not delay either vaccine due to concerns about co-administration; the safety profile supports same-day administration. 5, 3
Safety Profile
Expected Adverse Events
MMR commonly causes injection-site reactions (erythema, pain, swelling) and systemic symptoms including fever (occurring in up to 67% of recipients) and rash (measles-like or rubella-like in approximately 3% of cases). 1
JYNNEOS most commonly causes injection-site reactions, which are consistent with prelicensure studies and occur at similar rates whether given intradermally or subcutaneously. Serious adverse events are rare. 7, 8
When vaccines are co-administered, adverse events from each vaccine may occur independently, but there is no evidence of synergistic toxicity or increased serious adverse event rates. 3, 5
Documentation Requirements
- Record the specific anatomic site used for each vaccine, the route of administration, lot numbers, and date of administration in the patient's permanent medical record. 3
Common Pitfalls to Avoid
Do not wait for serologic testing before administering either vaccine unless specifically indicated (e.g., pregnancy screening before MMR). Serologic screening creates barriers to timely vaccination. 3
Do not defer vaccination because the manufacturer of a previously administered dose is unknown. Vaccines from different manufacturers are interchangeable. 4
Do not administer MMR to pregnant women or severely immunocompromised individuals receiving high-dose corticosteroids or other immunosuppressive therapy. 1
Do not forget the 28-day separation rule if vaccines are not given on the same day. This is a firm requirement for live viral vaccines. 1, 4